Literature DB >> 7761218

A prospective, controlled evaluation of home chemotherapy for children with cancer.

P Close1, E Burkey, A Kazak, P Danz, B Lange.   

Abstract

OBJECTIVES: Infusion of chemotherapy at home provides an alternative to hospitalization for children with cancer. Few programs of pediatric home chemotherapy have been described or evaluated. The purpose of this work was to compare prospectively chemotherapy in the hospital to chemotherapy at home with respect to billed medical charges, out-of-pocket expenses, and quality of life.
METHODS: Eligibility criteria for home therapy were defined. Parents and nurses were trained. Billed charges, loss of wages, out-of-pocket expenses, medical outcome, and quality of life of 14 patients for one course of chemotherapy in the hospital were compared with those for an identical course at home.
RESULTS: Daily charges for chemotherapy were $2329 +/- 627 in the hospital and $1865 +/- 833 at home; out-of-pocket costs, $68 +/- 31 and $11 +/- 6, respectively; and loss of income, $265 +/- 233 and $67 +/- 107, respectively. Patients' independence, well-being, appetite, mood, and school work were significantly better at home, and parental time at work and with the family was greater.
CONCLUSION: Administration of selected chemotherapy at home results in lower billed charges, reduced expenses, reduced loss of income for parents, and a more satisfying lifestyle for patients and parents.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7761218

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  14 in total

1.  Home delivery: chemotherapy and pizza?

Authors:  A M Young; D J Kerr
Journal:  BMJ       Date:  2001-04-07

2.  Pediatric Cancer CareLink--supporting home management of childhood leukemia.

Authors:  D M Goldsmith; L B Silverman; C Safran
Journal:  Proc AMIA Symp       Date:  2002

3.  Home intravenous therapy: Accessibility for Canadian children and youth.

Authors:  Dl Moore; R Bortolussi
Journal:  Paediatr Child Health       Date:  2011-02       Impact factor: 2.253

Review 4.  Impacts on health outcomes and on resources utilization for anticancer drugs injection at home, a complex intervention: a systematic review.

Authors:  Bénédicte Mittaine-Marzac; Emmanuel Bagaragaza; Joël Ankri; Philippe Aegerter; Matthieu De Stampa
Journal:  Support Care Cancer       Date:  2021-03-25       Impact factor: 3.603

5.  Outpatient treatment for people with cancer who develop a low-risk febrile neutropaenic event.

Authors:  Rodolfo Rivas-Ruiz; Miguel Villasis-Keever; Guadalupe Miranda-Novales; Osvaldo D Castelán-Martínez; Silvia Rivas-Contreras
Journal:  Cochrane Database Syst Rev       Date:  2019-03-19

6.  Comparison of in-patient costs for children treated on the AAML0531 clinical trial: A report from the Children's Oncology Group.

Authors:  Kelly D Getz; Yimei Li; Todd A Alonzo; Matthew Hall; Robert B Gerbing; Lillian Sung; Yuan-Shung Huang; Staci Arnold; Alix E Seif; Tamara P Miller; Rochelle Bagatell; Brian T Fisher; Peter C Adamson; Alan Gamis; Ron Keren; Richard Aplenc
Journal:  Pediatr Blood Cancer       Date:  2015-05-06       Impact factor: 3.167

7.  Compliance, satisfaction, and quality of life of patients with colorectal cancer receiving home chemotherapy or outpatient treatment: a randomised controlled trial.

Authors:  J M Borras; A Sanchez-Hernandez; M Navarro; M Martinez; E Mendez; J L Ponton; J A Espinas; J R Germa
Journal:  BMJ       Date:  2001-04-07

Review 8.  Oral cancer chemotherapy in paediatric patients: obstacles and potential for development and utilisation.

Authors:  W A Bleyer; M G Danielson
Journal:  Drugs       Date:  1999       Impact factor: 9.546

9.  Payer and race/ethnicity influence length and cost of childhood cancer hospitalizations.

Authors:  Sarah B Whittle; Michelle A Lopez; Heidi V Russell
Journal:  Pediatr Blood Cancer       Date:  2019-04-16       Impact factor: 3.167

10.  Home care--a safe and attractive alternative to inpatient administration of intensive chemotherapies.

Authors:  François Lüthi; Nadia Fucina; Nathalie Divorne; Brigitte Santos-Eggimann; Christine Currat-Zweifel; Patricia Rollier; Jean-Blaise Wasserfallen; Nicolas Ketterer; Serge Leyvraz
Journal:  Support Care Cancer       Date:  2011-03-08       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.